# Lions Capital

> Lions Capital is a VC fund backing Life Science and Biotechnology. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 4
- Last investment: May 2026
- Lead investor: 50%
- Last updated: Aug 2026

Lions Capital is an investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Life Science | 1 | 25% |
| Biotechnology | 1 | 25% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 25% |
| Series A | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Kanvas Biosciences | Kanvas Biosciences developed cutting-edge imaging technology for microbial detection, providing unmatched speed, breadth, and adaptability. Kanvas aims to transform microbial research and infectious disease diagnostics through innovative imaging technology of the next generation. | $48M | Series A | May 05, 2026 |  |
| Kanvas Biosciences | Kanvas Biosciences developed cutting-edge imaging technology for microbial detection, providing unmatched speed, breadth, and adaptability. Kanvas aims to transform microbial research and infectious disease diagnostics through innovative imaging technology of the next generation. | $12.5M | Series A | Jul 01, 2024 |  |
| Cogito | Cogito is a computer service company that enhances the emotional intelligence of phone professionals by applying behavioral science through artificial intelligence and machine learning. Its software evaluates hundreds of behavioral signals through voice to provide live conversation coaching for agents and a real-time measure of customer experiencefor every call. |  |  | Oct 24, 2023 |  |
| Kanvas Biosciences | Kanvas Biosciences developed cutting-edge imaging technology for microbial detection, providing unmatched speed, breadth, and adaptability. Kanvas aims to transform microbial research and infectious disease diagnostics through innovative imaging technology of the next generation. | $12M | Seed | Jun 22, 2023 |  |

4 of 4 investments shown.

## Co-investors
- [DCVC](https://shizune.co/investors/profile/data-collective) — VC Fund, 2 deals together
- [Germin8 Ventures](https://shizune.co/investors/profile/germin8-ventures) — VC Fund, 2 deals together
- [Ki Tua Fund](https://shizune.co/investors/profile/ki-tua-fund) — VC Fund, 2 deals together
- [Pangaea Ventures](https://shizune.co/investors/profile/pangaea-ventures) — VC Fund, 2 deals together
- [Triple Impact Capital](https://shizune.co/investors/profile/triple-impact-capital) — VC Fund, 2 deals together
- [Uncommon Denominator](https://shizune.co/investors/profile/uncommon-denominator-vc) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Lions Capital invest in?

Lions Capital invests primarily in Life Science and Biotechnology startups, most often at Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Lions Capital last invest?

The most recent investment recorded for Lions Capital closed in May 2026. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co